{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:57:10Z","timestamp":1747173430277,"version":"3.40.5"},"reference-count":19,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"unspecified","delay-in-days":158,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This work was funded by the Dutch Ministry of Health, Welfare and Sports."}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Surveillance data shows a geographical overlap between the early coronavirus disease 2019 (COVID-19) pandemic and the past Q fever epidemic (2007\u20132010) in the Netherlands. We investigated the relationship between past Q fever and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in 2020\/2021, using a retrospective matched cohort study.<\/jats:p>\n\t  <jats:p>In January 2021, former Q fever patients received a questionnaire on demographics, SARS-CoV-2 test results and related hospital\/intensive care unit (ICU) admissions. SARS-CoV-2 incidence with 95% confidence intervals (CI) in former Q fever patients and standardised incidence ratios (SIR) to compare to the age-standardised SARS-CoV-2 incidence in the general regional population were calculated.<\/jats:p>\n\t  <jats:p>Among 890 former Q fever patients (response rate: 68%), 66 had a PCR-confirmed SARS-CoV-2 infection. Of these, nine (14%) were hospitalised and two (3%) were admitted to ICU. From February to June 2020 the SARS-CoV-2 incidence was 1573\/100 000 (95% CI 749\u20132397) in former Q fever patients and 695\/100 000 in the general population (SIR 2.26; 95% CI 1.24\u20133.80). The incidence was not significantly higher from September 2020 to February 2021.<\/jats:p>\n\t  <jats:p>We found no sufficient evidence for a difference in SARS-CoV-2 incidence or an increased severity in former Q fever patients <jats:italic>vs.<\/jats:italic> the general population during the period with widespread SARS-CoV-2 testing availability (September 2020\u2013February 2021). This indicates that former Q fever patients do not have a higher risk of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.1017\/s0950268822001029","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T02:19:43Z","timestamp":1654654783000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020\u20132021"],"prefix":"10.1017","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-0026","authenticated-orcid":false,"given":"Elisabeth Maria","family":"den Boogert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit M. A.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-9088","authenticated-orcid":false,"given":"Cornelia C. H.","family":"Wielders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariene","family":"Rietveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"RIVM COVID-19 Surveillance and Epidemiology Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianne B.","family":"van Gageldonk-Lafeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"volume-title":"Q Fever Guideline","year":"2018","key":"S0950268822001029_ref4"},{"volume-title":"Covid-19 Guideline","year":"2021","key":"S0950268822001029_ref1"},{"volume-title":"Q Fever","year":"2021","key":"S0950268822001029_ref8"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref6","DOI":"10.1371\/journal.pone.0131848"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref14","DOI":"10.1007\/s10640-020-00491-4"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref12","DOI":"10.1371\/journal.pmed.1003374"},{"volume-title":"Research on COVID-19 in the Netherlands","year":"2021","key":"S0950268822001029_ref19"},{"unstructured":"10. Nielen, MMJ , Poos, MJJC and Gommer, AM (2021) Population with chronic disease known to the General Practitioner [in Dutch]. Available at https:\/\/www.volksgezondheidenzorg.info\/onderwerp\/chronische-aandoeningen-en-multimorbiditeit\/cijfers-context\/huidige-situatie#node-aantal-mensen-met-chronische-aandoening-bekend-bij-de-huisarts.","key":"S0950268822001029_ref10"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref15","DOI":"10.1126\/sciadv.abd4049"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref11","DOI":"10.1002\/jmv.26424"},{"volume-title":"Study on Q Fever and COVID-19","year":"2021","author":"van Gageldonk-Lafeber","key":"S0950268822001029_ref9"},{"volume-title":"NSL 2020 Monitoring Report","year":"2020","author":"de Smet","key":"S0950268822001029_ref13"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref5","DOI":"10.1093\/cid\/cir234"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref7","DOI":"10.2807\/ese.17.03.20058-en"},{"volume-title":"COVID-19 Numbers per Municipality per Publication Date","year":"2021","key":"S0950268822001029_ref2"},{"key":"S0950268822001029_ref3","first-page":"150","article-title":"Is former Q fever associated with serious illness or death of COVID-19 patients? [in Dutch]","volume":"28","author":"Mulder","year":"2020","journal-title":"Nederlands Tijdschrift voor Medische Microbiologie"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref16","DOI":"10.1016\/j.scitotenv.2020.138605"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref17","DOI":"10.1016\/j.envpol.2020.115859"},{"doi-asserted-by":"publisher","key":"S0950268822001029_ref18","DOI":"10.1183\/13993003.01361-2020"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268822001029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T07:58:31Z","timestamp":1655884711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268822001029\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":19,"alternative-id":["S0950268822001029"],"URL":"https:\/\/doi.org\/10.1017\/s0950268822001029","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"type":"print","value":"0950-2688"},{"type":"electronic","value":"1469-4409"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2022. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e116"}}